Aug 12, 2020
MobileODT completed $4 million series round C
Jun 16, 2020
Support for cervical cancer screening using Pap and HPV testing together continues to grow among health care providers and women
Apr 20, 2020
Precigen Announces Clearance of IND to Initiate Phase I/II Study for First-in-Class PRGN-2009 AdenoVerse(TM) Immunotherapy to Treat HPV-positive (HPV+) Solid Tumors
Mar 04, 2020
The World Market for Cervical Cancer Drugs, Forecast to 2030 - Insights Into Avastin, Bevacizumb, Blemocin, Blenoxane, and More
Mar 02, 2020
Inovio Pharmaceuticals to Report Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020
Mar 02, 2020
Inovio Pharmaceuticals to Report Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020
Feb 14, 2020
The global HPV testing market is expected to grow at a CAGR of over 12% during the period 2019-2025
Feb 13, 2020
2020-2025 Human Papillomavirus (HPV) Testing Industry Report - Roche, Qiagen, Hologic and Abbott are Dominating the Competition
Feb 12, 2020
The Global Human Papillomavirus (HPV) Testing Market to Reach Revenues of Over $1 Billion During the Period 2020 -2025 - Market Research by Arizton
Feb 03, 2020
Inovio Publishes Patient Benefit Results From A Pilot Clinical Study in Recurrent Respiratory Papillomatosis (RRP), A Rare Disease Caused by HPV Infections
Jan 14, 2020
ASKA Pharmaceutical Co., Ltd. and KinoPharma, Inc. Enter into Option Agreement for Treatment of Cervical Dysplasia
Nov 12, 2019
BD Submits Pre-Market Approval Supplement to FDA for BD Onclarity(TM) HPV Test with Extended Genotyping Capabilities
Oct 14, 2019
ISA Pharmaceuticals B.V. Receives EUR 20m Loan From European Investment Bank
Sep 18, 2019
If you could get a vaccination that would prevent cancer - would you?
Sep 18, 2019
HPV Associated Disorders Market Size Worth $23.2 Billion By 2026: Grand View Research, Inc.
Aug 08, 2019
Inovio Pharmaceuticals Reports 2019 Second Quarter Financial Results
Jul 02, 2019
Asieris and Photocure Enter into a License Agreement for World-Wide Development and Commercialization of Cevira®
Jun 26, 2019
Inovio Completes Enrollment of VGX-3100 Phase 3 Trial (REVEAL 1) for the Treatment of HPV-Related Cervical Pre-cancer
Jun 19, 2019
Global Cervical Cancer Market Spotlight, 2019-2026 - Overview, Key Takeaways, Background, Treatments, Epidemiology, Marketed Drugs, Pipeline Drugs, Licensing, Key Events
May 22, 2019
Tencent Miying Launches AI-supported Auxiliary Diagnostic System